RV-1001

N/A

Report date: 2023/03/26 16:39:11
NME

Base Information

Drug NameRV-1001
Drug Alias NameRV-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIncozen Therapeutics Pvt LtdRhizen Pharmaceuticals Sa
China Registration ClassN/A

Develop Information

Active CompaniesIncozen Therapeutics Pvt LtdRhizen Pharmaceuticals Sa
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A